In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before ...
DISABLED ENTREPRENEUR UK on MSN6d
Therapies for Multiple Sclerosis
Multiple sclerosis is a complex and challenging condition to manage, but a wide range of therapies offers hope for patients.
The report explains that Pharmac’s current funding model is a cost utility analysis (CUA), which is a subset of cost effectiveness analysis. In this, Pharmac weighs up the direct healthcare costs and ...
Chair of the Meningitis Foundation, Gerard Rushton says he fully supports MSNZ and its call for Pharmac to adopt a new funding evaluation model that considers more than just the direct healthcare ...
Thought Leader in Brain Health Joins Richard Stark and Company Co-Founders to Accelerate Innovation in Precision MedicineMONTREAL, QC / ACCESSWIRE / October 15, 2024 / Perceiv AI, a leading precision ...
Furthest ahead in the pipeline is tolebrutinib, developed by Paris-based Sanofi to potentially treat SPMS, PPMS and relapsing forms of MS. The investigational agent is an oral central nervous system ...
An overhaul of the way Pharmac decides to fund drugs for people with chronic long term diseases is needed, say health ...
Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...
The following is a summary of “Recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis,” published in the September 2024 issue of Neurology by Coerver et al. Ocrelizumab ...
The rollout of COVID and flu vaccines for older adults, care home residents and those with long term health conditions kicks off today (Thursday 3 October) as the NHS drive to protect against a ...
Anti-CD20 therapies like Ocrevus (ocrelizumab) and rituximab appear to be ineffective at slowing disability progression in people with primary progressive multiple sclerosis (PPMS), a form of the ...
The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease. Multiple sclerosis occurs when the body ...